drugset / Trial / NCT04240314

AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications.

NCT04240314 ↗

NaSingle-groupOpen-labelTreatment

Summary

Open-label, single dose clinical trial of scAAV9.U7.ACCA via peripheral limb vein injection for Duchenne muscular dystrophy boys who have a duplication of exon 2.

Timeline

Start
2020-01-15
Primary completion
2023-11-13
Completion
2025-07-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject scAAV9.U7.ACCA Unknown — Intravenous